Dr. Peter William Macintosh, MD

Dr. Macintosh practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Macintosh's NPI, 1528229440, was assigned on June 23, 2008. Dr. Macintosh holds Illinois license 036127245.

Dr. Macintosh's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Macintosh's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Macintosh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Macintosh practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Macintosh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Macintosh is licensed in Illinois.

CMS data shows 456 Medicare services from Dr. Macintosh across 9 procedure codes in 2024, for 245 Medicare patients. Medicare paid $21,876 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 245 Medicare patients who saw Dr. Macintosh in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Macintosh's median patient age at 66, with 66% women.

In 2024, Dr. Macintosh wrote 55 Medicare Part D claims for 19 patients. 87% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $1,294 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Macintosh for performance year 2024, reported as part of a group. Dr. Macintosh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 36 papers to Dr. Macintosh, published from 2014 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Tomography, X-Ray Computed, Eyelids and Magnetic Resonance Imaging. Dr. Macintosh has published most often in Neuroophthalmology. Dr. Macintosh's most frequent co-authors are Heather Elspeth Moss, MD, PhD, Anna Michelle Stagner, MD and Pooja V. Bhat, MD.

Dmand AI links Dr. Macintosh to 2 clinical trials. Conditions studied include Optic Neuropathy, Ischemic, Pseudotumor Cerebri and Intracranial Hypertension.

CMS Open Payments shows 12 general payments to Dr. Macintosh from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $392.